Akinlade Akinyele Taofiq, Ogbera Anthonia Okeoghene, Fasanmade Olufemi Adetola, Olamoyegun Michael Adeyemi
Department of Medicine, General Hospital, Odan, Lagos Nigeria.
Lagos State University Teaching Hospital, Ikeja, Lagos Nigeria.
Int Arch Med. 2014 Nov 28;7:50. doi: 10.1186/1755-7682-7-50. eCollection 2014.
HE are common acute complications of diabetes mellitus (DM) and include diabetic ketoacidosis (DKA), normo-osmolar hyperglycemic state (NHS) and hyperosmolar hyperglycemic state (HHS). They contribute a lot to the mortality and morbidity of DM. The clinical features include dehydration, hyperglycemia, altered mental status and ketosis. The basic mechanism of HE is a reduction in the net effective action of circulating insulin, resulting in hyperglycemia and ketonemia (in DKA) causing osmotic diuresis and electrolytes loss. Infection is a common precipitating factor. Measurement of serum C-peptide provides an accurate assessment of residual β-cell function and is a marker of insulin secretion in DM patients.
To assess the level of pancreatic beta cell function in HE patients, using the serum C-peptide.
The biodata and clinical characteristics of the 99 subjects were collated using a questionnaire. All subjects had their serum C-peptide, glucose, electrolytes, urea, creatinine levels, urine ketones determined at admission. Results of statistical analysis were expressed as mean ± standard deviation (SD). A p value <0.05 was regarded statistically significant. Correlation between levels of serum C-peptide and admission blood glucose levels and the duration of DM respectively was done.
The mean age of the subjects was 51 (SD ± 16) years and comparable in both sexes. Mean duration of DM was 6.3 (SD ± 7.1) years, with 35% newly diagnosed at admission. The types of HE in this study are: DKA (24.7%), NHS (36.1%), and HHS (39.2%). Mean blood glucose in this study was 685 mg/dL, significantly highest in HHS and lowest in NHS. Mean serum C-peptide level was 1.6 ng/dL. It was 0.9 ng/dL in subjects with DKA and NHS while 2.7 ng/dL in HHS (p>0.05). Main precipitating factors were poor drug compliance, new-onset of DM and infection.
Most (70%) of subjects had poor pancreatic beta cell function, this may be a contributory factor to developing HE. Most subjects with high C-peptide levels had HHS.
高血糖危象(HE)是糖尿病(DM)常见的急性并发症,包括糖尿病酮症酸中毒(DKA)、正常血糖高渗状态(NHS)和高渗高血糖状态(HHS)。它们对糖尿病的死亡率和发病率有很大影响。临床特征包括脱水、高血糖、精神状态改变和酮症。高血糖危象的基本机制是循环胰岛素的净有效作用降低,导致高血糖和酮血症(在DKA中),引起渗透性利尿和电解质丢失。感染是常见的诱发因素。血清C肽的测定可准确评估残余β细胞功能,是糖尿病患者胰岛素分泌的标志物。
使用血清C肽评估高血糖危象患者的胰腺β细胞功能水平。
通过问卷整理99名受试者的生物数据和临床特征。所有受试者在入院时测定血清C肽、血糖、电解质、尿素、肌酐水平及尿酮。统计分析结果以平均值±标准差(SD)表示。p值<0.05被视为具有统计学意义。分别分析血清C肽水平与入院血糖水平及糖尿病病程之间的相关性。
受试者的平均年龄为51(标准差±16)岁,男女相当。糖尿病平均病程为6.3(标准差±7.1)年,35%在入院时新诊断。本研究中高血糖危象的类型为:DKA(24.7%)、NHS(36.1%)和HHS(39.2%)。本研究中的平均血糖为685mg/dL,在HHS中显著最高,在NHS中最低。平均血清C肽水平为1.6ng/dL。DKA和NHS受试者中为0.9ng/dL,而HHS中为2.7ng/dL(p>0.05)。主要诱发因素为药物依从性差、新发糖尿病和感染。
大多数(70%)受试者胰腺β细胞功能较差,这可能是发生高血糖危象的一个促成因素。大多数C肽水平高的受试者患有HHS。